- Report
- June 2025
- 150 Pages
Global
From €5306EUR$5,950USD£4,601GBP
- Report
- April 2025
- 147 Pages
Global
From €3566EUR$3,999USD£3,092GBP
- Report
- January 2026
- 281 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 467 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 277 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 370 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 478 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 197 Pages
Global
From €3513EUR$3,939USD£3,046GBP
- Report
- August 2025
- 193 Pages
Global
From €3513EUR$3,939USD£3,046GBP
- Report
- August 2025
- 187 Pages
Global
From €3513EUR$3,939USD£3,046GBP
- Report
- May 2025
- 114 Pages
Global
From €4236EUR$4,750USD£3,673GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2229EUR$2,500USD£1,933GBP
- Report
- September 2025
- 250 Pages
Global
From €4004EUR$4,490USD£3,472GBP
- Report
- September 2025
- 250 Pages
Global
From €4004EUR$4,490USD£3,472GBP
- Report
- July 2025
- 175 Pages
Global
From €4004EUR$4,490USD£3,472GBP
- Report
- November 2025
- 185 Pages
Global
From €4013EUR$4,500USD£3,480GBP
- Report
- January 2026
- 390 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 277 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2487EUR$2,789USD£2,157GBP
- Report
- June 2025
- 400 Pages
Global
From €4413EUR$4,949USD£3,827GBP

The Dry Eye Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Dry Eye Drugs are used to treat the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears or the tears evaporate too quickly. These drugs can be administered topically, orally, or through injection. Commonly used Dry Eye Drugs include artificial tears, anti-inflammatory medications, and immunomodulators.
Some companies in the Dry Eye Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, Shire, and Sun Pharmaceuticals. Show Less Read more